James P. Boylan Portfolio
Invests via Enavate Sciences GP LLC | Managed by James P. Boylan
Invests via Enavate Sciences GP LLC
Managed by James P. Boylan
Automatically Tracked
James P. Boylan Profile
James P. Boylan is a seasoned financial executive with a rich history in the corporate finance landscape. His career spans diverse roles, where he has showcased adeptness in operational leadership and strategic business development within dynamic market conditions. With extensive experience at various financial institutions, he possesses a nuanced understanding of capital markets, which has shaped his contributions to organizational growth and innovation initiatives. Boylan's ability to bridge technical expertise with insightful management practices positions him as a pivotal player in driving company performance and stakeholder value.
James P. Boylan is a seasoned financial executive with a rich history in the corporate finance landscape. His career spans diverse roles, where he has showcased adeptness in operational leadership and strategic business development within dynamic market conditions. With extensive experience at various financial institutions, he possesses a nuanced understanding of capital markets, which has shaped his contributions to organizational growth and innovation initiatives. Boylan's ability to bridge technical expertise with insightful management practices positions him as a pivotal player in driving company performance and stakeholder value.
Investment Philosophy & Strategy
Operating within a landscape ripe for innovation, James P. Boylan leverages his extensive experience in financial leadership to identify unique investment opportunities that disrupt conventional norms. His approach emphasizes operational efficiencies and strategic market positioning, allowing him to capitalize on emerging trends effectively. By aligning investments with high-growth potential sectors, he seeks out ventures capable of redefining industry benchmarks. The focus remains on fostering sustainable business models while enhancing shareholder value through informed decision-making and proactive engagement with stakeholders.
Operating within a landscape ripe for innovation, James P. Boylan leverages his extensive experience in financial leadership to identify unique investment opportunities that disrupt conventional norms. His approach emphasizes operational efficiencies and strategic market positioning, allowing him to capitalize on emerging trends effectively. By aligning investments with high-growth potential sectors, he seeks out ventures capable of redefining industry benchmarks. The focus remains on fostering sustainable business models while enhancing shareholder value through informed decision-making and proactive engagement with stakeholders.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
-25.54%
Gain -1.6%
Monthly
-9.36%
Yearly
-25.54%
Drawdown
31.88%
$0
Equity
Holdings
$0
Investment
$0
-$35.56M
Profit -$1.68M
Realized
-$35.56M
Unrealized
$0
Dividends
$0
Goals
Avg. 0% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
-1.6%
Profit
-$1.68M
Win %
20%
This Week
Compared To Last Week
Gain
-10.95%
Profit
-$12.75M
Win %
20%
This Month
Compared to last month
Gain
-13.41%
Profit
-$16.06M
Win %
20%
This Year
Compared to last year
Gain
-25.54%
Profit
-$35.56M
Win %
20%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 5 | Longs Won 1/5 20% | Profit Factor 0.08 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $11.51M |
| Average Win $3.5M | Best Trade (Mar 30) $3.5M | Sharpe Ratio 0 |
| Average Loss -$11.16M | Worst Trade (Mar 30) -$25.38M | Z-Score -0.2 (16.17%) |
| Commissions $0 | Avg. Trade Length 2m 4w 1d | Expectancy -$7.11M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for James P. Boylan?
The largest contributions to the portfolio's profits come from the following stocks: Compass Therapeutics Inc - $3.5M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Upstream Bio, Inc - $25.38M, Immunome Inc - $13.53M, Camp4 Therapeutics Corp - $4.62M, and Zenas BioPharma, Inc - $1.09M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
How stable are James P. Boylan's monthly returns?
James P. Boylan's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can James P. Boylan's strategy be considered aggressive or moderate?
It is difficult to clearly classify James P. Boylan's strategy as aggressive or moderate based on the available data. A more complete performance and portfolio structure history would be needed to assess the overall risk profile with confidence.
Should beginners follow James P. Boylan's strategy?
It is difficult to determine whether James P. Boylan's strategy is suitable for beginners based on the available data. A more complete view of performance, risk, and portfolio structure would be needed for a confident assessment.
